Analyser av Gasporox

Gasporox: Set to issue convertible debt of SEK13m - Redeye

Redeye comments on Gasporox’s convertible debt financing.

Gasporox: LTM reacceleration expected in Q1 2025 - Redeye

Redeye provides an update on Gasporox following its Q3 2024 report, which was below expectations but continued net sales growth and positive...

Redeye • 25 Oct 10:47

Gasporox Q3 2024: Growth but below expectations - Redeye

Redeye notes that Gasporox's report came in below Redeye Estimates (RRe) across the board while producing its highest net sales in Q3 yet.

Redeye • 24 Oct 11:59

Gasporox: Close to sustained profitability - Redeye

Redeye states that Q2 2024 was solid, beating estimates across the board.

Redeye • 08 Aug 07:34

Gasporox Q2 2024: Solid beat in a tough quarter - Redeye

Redeye states the report was solid, beating its net sales forecast by 25% and growing 19% y/y despite a tough comparison quarter and showing...

Redeye • 07 Aug 08:53

Gasporox: Executing its long-term strategy - Redeye

Gasporox’s results closely align with RRe expectations, showing seven quarters of positive EBITDA driven by sales from VialArch, GPX1500, an...

Redeye • 23 Apr 13:45

Gasporox Q1 2024: Just as expected - Redeye

Redeye states the report aligned with its estimates, and Gasporox has now produced positive EBITDA seven consecutive quarters in a row, thus...

Redeye • 23 Apr 08:54

Gasporox: Orders up, but earnings linger for 2024 - Redeye

Redeye states that net sales were slightly higher than expected, but OPEX was also higher.

Redeye • 16 Feb 07:35

Gasporox Q4 2023: Solid results and cash flow - Redeye

Redeye comments on Gasporox's Q4 report, which was in line with estimates.

Redeye • 15 Feb 10:02

Gasporox: Received the largest order in its history - Redeye

Gasporox has secured a SEK9.1m order for its VialArch product from MaxCann, with deliveries scheduled throughout 2024 in three batches.

Redeye • 14 Dec 2023 14:21

Gasporox: Catching its breath after a strong H1 2023 - Redeye

Redeye provides an update on Gasporox after its Q3 2023 report.

Redeye • 08 Nov 2023 08:30

Gasporox Q3 2023: Below expectations but still positive EBITDA - Redeye

Redeye comments on Gasporox Q3 2023 report which came in below estimates.

Redeye • 07 Nov 2023 08:49

Gasporox: Quick comment on AutoMap agreement - Redeye

Redeye provides a quick comment on Gasporox’s AutoMap agreement worth SEK3m with Weber Maschinenbau GmbH (Weber), a distinguished German man...

Redeye • 23 Oct 2023 10:54

Gasporox Q2 2023: Sharp performance across the board - Redeye

Redeye provides an update after Gasprox’s Q2’23 report.

Redeye • 10 Aug 2023 07:20

Gasporox Q2'23: Close to tripel digit beat on the top line - Redeye

Redeye comments on Gasporox’s Q2’23 report, which was significantly stronger than expected on all items.

Redeye • 09 Aug 2023 09:16

Gasporox: Best quarter yet - Redeye

Redeye comments on Gasporox Q1'23 report which beat expectations across the board.

Redeye • 28 Apr 2023 09:47

Gasporox: Three consecutive EBITDA-positive quarters - Redeye

Gasporox beat our expectations by 34% on the top line with positive quarterly EBITDA.

Redeye • 27 Apr 2023 10:21

Gasporox: Managed for long-term value creation - Redeye

Redeye comments on Gasporox Q4'22 report which came in lighter than expected.

Redeye • 01 Mar 2023 07:46

Gasporox: Weak quarter, strong order book - Redeye

Redeye states that the Q4 report was weaker than expected with net sales coming in 43% lower than expected and EBITDA 98% lower than expecte...

Redeye • 28 Feb 2023 08:57

Gasporox: Keeping its Phot-on the Gas - Redeye

Redeye states the Q3 report was strong across the board.

Redeye • 14 Nov 2022 07:47

Gasporox Q3’22: Significant Beat, Positive EBITDA - Redeye

Redeye states Gasporox report was strong with beats accross the board.

Redeye • 10 Nov 2022 09:30

Gasporox: Set to Issue Convertible Note - Redeye

Gasprox announced yesterday that it plans to issue a convertible note worth SEK 5.

Redeye • 15 Sep 2022 15:56

Gasporox: Bright Future Ahead - Redeye

Redeye initiates coverage on Gasporox, a manufacturer of laser-based quality assurance and testing equipment.

Redeye • 02 Sep 2022 08:21

Börskollen

För dig med koll på börsen